Asthma: Pathogenesis and Management
Start with the big picture
Asthma pathogenesis involves interacting immune, genetic, and environmental factors. Th2 cytokines help drive IgE production and eosinophilic inflammation, while Th17 activity can contribute to neutrophilic inflammation, particularly in severe or steroid-resistant disease. Early allergen-related bronchoconstriction may be followed hours later by a phase of edema and inflammation. Repeated inflammation can remodel the airways, including changes to smooth muscle, mucus-producing cells, and the basement membrane. The topic also surveys diagnosis through spirometry and biomarkers, asthma phenotypes, and stepwise pharmacologic and non-pharmacologic management. Together, these areas show how disease mechanisms relate to assessment and treatment choices.
What you'll learn
- Describe the roles of Th2 and Th17 immunity in asthma inflammation.
- Identify key mediators and distinguish early from late exacerbation phases.
- Explain how genetic and environmental factors contribute to asthma.
- Outline how spirometry and biomarkers support asthma assessment.
- Summarize the structure of stepwise asthma management and key drug classes.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.